Cfo4 Life Group, LLC Novartis Ag Transaction History

Cfo4 Life Group, LLC

$559 Million
Q4 2024

A detailed history of Cfo4 Life Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cfo4 Life Group, LLC holds 6,619 shares of NVS stock, worth $737,886. This represents 0.12% of its overall portfolio holdings.

Number of Shares

6,619

Previous 6,240 6.07%

Holding current value

$737,886

Previous $717,000 10.18%

% of portfolio

0.12%

Previous 0.13%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$96.78 - $117.18 $36,679 - $44,411	379 Added 6.07%	6,619 $644,000
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $96,366 - $109,768	908 Added 17.03%	6,240 $717,000
Q2 2024 Jul 31, 2024	SELL	$92.57 - $107.37 $99,420 - $115,315	-1,074 Reduced 16.77%	5,332 $567,000
Q1 2024 May 06, 2024	SELL	$95.27 - $108.47 $58,019 - $66,058	-609 Reduced 8.68%	6,406 $619,000
Q4 2023 Jan 24, 2024	SELL	$92.27 - $101.54 $12,548 - $13,809	-136 Reduced 1.9%	7,015 $708,000
Q3 2023 Oct 30, 2023	BUY	$94.73 - $105.13 $83,930 - $93,145	886 Added 14.14%	7,151 $728,000
Q2 2023 Aug 07, 2023	BUY	$92.52 - $104.91 $48,387 - $54,867	523 Added 9.11%	6,265 $632,000
Q1 2023 May 03, 2023	SELL	$80.03 - $92.81 $54,340 - $63,017	-679 Reduced 10.57%	5,742 $528,000
Q4 2022 Feb 03, 2023	BUY	$75.55 - $92.52 $65,350 - $80,029	865 Added 15.57%	6,421 $582,000
Q3 2022 Oct 19, 2022	BUY	$74.61 - $87.26 $6,192 - $7,242	83 Added 1.52%	5,556 $422,000
Q2 2022 Jul 20, 2022	SELL	$80.52 - $93.75 $12,802 - $14,906	-159 Reduced 2.82%	5,473 $453,000
Q1 2022 May 02, 2022	SELL	$80.11 - $90.62 $15,701 - $17,761	-196 Reduced 3.36%	5,632 $494,000
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $28,213 - $31,198	-354 Reduced 5.73%	5,828 $510,000
Q3 2021 Oct 12, 2021	BUY	$81.78 - $95.14 $28,950 - $33,679	354 Added 6.07%	6,182 $506,000
Q2 2021 Jul 14, 2021	SELL	$85.24 - $94.15 $2,045 - $2,259	-24 Reduced 0.41%	5,828 $532,000
Q1 2021 Apr 20, 2021	BUY	$83.5 - $98.47 $16,032 - $18,906	192 Added 3.39%	5,852 $500,000
Q3 2020 Oct 13, 2020	SELL	$82.14 - $91.0 $18,399 - $20,384	-224 Reduced 3.81%	5,660 $492,000
Q2 2020 Jul 15, 2020	BUY	$80.93 - $91.1 $5,422 - $6,103	67 Added 1.15%	5,884 $514,000
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $13,073 - $18,316	-185 Reduced 3.08%	5,817 $480,000
Q4 2019 Jan 22, 2020	SELL	$84.35 - $95.37 $6,579 - $7,438	-78 Reduced 1.28%	6,002 $568,000
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $254,481 - $280,423	-2,975 Reduced 32.85%	6,080 $528,000
Q2 2019 Jul 29, 2019	SELL	$75.4 - $92.8 $5,655 - $6,960	-75 Reduced 0.82%	9,055 $827,000
Q1 2019 Apr 22, 2019	SELL	$75.32 - $86.15 $226,788 - $259,397	-3,011 Reduced 24.8%	9,130 $878,000
Q4 2018 Feb 01, 2019	SELL	$73.66 - $82.02 $62,463 - $69,552	-848 Reduced 6.53%	12,141 $1.04 Million
Q3 2018 Oct 25, 2018	SELL	$66.94 - $77.43 $156,572 - $181,108	-2,339 Reduced 15.26%	12,989 $1.12 Million
Q2 2018 Aug 01, 2018	BUY	$64.91 - $73.36 $994,940 - $1.12 Million	15,328 New	15,328 $1.16 Million

Others Institutions Holding NVS

# of Institutions

1,487

Shares Held

131M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfo4 Life Group, LLC with notifications on news.

Account

Cfo4 Life Group, LLC Novartis Ag Transaction History